MedPath

Feasibility and efficacy of an aroma therapeutic nurse led intervention to promote sleep in the critically ill – a randomised controlled pilot study

Not Applicable
Recruiting
Conditions
F51.0
F51.1
F51.2
F51.8
F51.9
Nonorganic insomnia
Nonorganic hypersomnia
Nonorganic disorder of the sleep-wake schedule
Other nonorganic sleep disorders
Nonorganic sleep disorder, unspecified
Registration Number
DRKS00012646
Lead Sponsor
Pflegedirektorin, Universitätsklinukum Schleswig-Holstein, Campus Lübeck
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Given consent, at least 1 night at the intensive care unit, no continuous analgesic sedation, no regularly application of benzodiazepines, hypnotics or neuroleptic agents at night. Stay in a single bedroom, sufficient knowledge of German to understand the aim and course of the study, to give consent and to be able to answer the RCSQ).

Exclusion Criteria

Sedated (RASS=-4/-5) and delirious patients (CAM –ICU +) will be excluded (the latter assessment are regularly used at the participating icu`s). Furthermore, patients with dementia, bronchial asthma, acute exacerbation of copd and or bronchial hyperreactivity and an insufficient knowledge of the German language. Another exclusion criterion is an allergic reaction of one of the used oils.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
-Objective Measurement of sleep depth and length using the Bispectral Index (BIS™ 2-Kanal Monitor /Medtronic GmbH) during 11.00-05.00 p.m. <br><br>-Self-perception of the participant will be assessed the following morning(between 09.00-11.00 a.m.), using the German version of the Richards Campbell Sleep Questionnaire<br>
Secondary Outcome Measures
NameTimeMethod
Evaluation of participants in regard of the perceived effectiveness of the intervention,<br>Characteristics,<br>Demographics,<br>Process evaluation
© Copyright 2025. All Rights Reserved by MedPath